BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23694700)

  • 1. Adjusting for background mutation frequency biases improves the identification of cancer driver genes.
    Evans P; Avey S; Kong Y; Krauthammer M
    IEEE Trans Nanobioscience; 2013 Sep; 12(3):150-7. PubMed ID: 23694700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
    Zhang D; Xia J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
    Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
    Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional relevance of somatic synonymous mutations in melanoma and other cancers.
    Gotea V; Gartner JJ; Qutob N; Elnitski L; Samuels Y
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):673-84. PubMed ID: 26300548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsynonymous, synonymous and nonsense mutations in human cancer-related genes undergo stronger purifying selections than expectation.
    Chu D; Wei L
    BMC Cancer; 2019 Apr; 19(1):359. PubMed ID: 30991970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
    Bin Y; Wang X; Zhao L; Wen P; Xia J
    BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer.
    Rao Y; Ahmed N; Pritchard J; O'Brien EP
    BMC Bioinformatics; 2023 Dec; 24(1):462. PubMed ID: 38062391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evolution of synonymous codon usage in Populus.
    Ingvarsson PK
    BMC Evol Biol; 2008 Nov; 8():307. PubMed ID: 18983655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On measuring selection in cancer from subclonal mutation frequencies.
    Bozic I; Paterson C; Waclaw B
    PLoS Comput Biol; 2019 Sep; 15(9):e1007368. PubMed ID: 31557163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain landscapes of somatic mutations in cancer.
    Nehrt NL; Peterson TA; Park D; Kann MG
    BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive catalogue of somatic mutations from a human cancer genome.
    Pleasance ED; Cheetham RK; Stephens PJ; McBride DJ; Humphray SJ; Greenman CD; Varela I; Lin ML; Ordóñez GR; Bignell GR; Ye K; Alipaz J; Bauer MJ; Beare D; Butler A; Carter RJ; Chen L; Cox AJ; Edkins S; Kokko-Gonzales PI; Gormley NA; Grocock RJ; Haudenschild CD; Hims MM; James T; Jia M; Kingsbury Z; Leroy C; Marshall J; Menzies A; Mudie LJ; Ning Z; Royce T; Schulz-Trieglaff OB; Spiridou A; Stebbings LA; Szajkowski L; Teague J; Williamson D; Chin L; Ross MT; Campbell PJ; Bentley DR; Futreal PA; Stratton MR
    Nature; 2010 Jan; 463(7278):191-6. PubMed ID: 20016485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genomic landscape of cutaneous melanoma.
    Zhang T; Dutton-Regester K; Brown KM; Hayward NK
    Pigment Cell Melanoma Res; 2016 May; 29(3):266-83. PubMed ID: 26833684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison and integration of computational methods for deleterious synonymous mutation prediction.
    Cheng N; Li M; Zhao L; Zhang B; Yang Y; Zheng CH; Xia J
    Brief Bioinform; 2020 May; 21(3):970-981. PubMed ID: 31157880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Epistasis in Cancer Genomes: A Delicate Affair.
    van de Haar J; Canisius S; Yu MK; Voest EE; Wessels LFA; Ideker T
    Cell; 2019 May; 177(6):1375-1383. PubMed ID: 31150618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural selection on synonymous and nonsynonymous mutations shapes patterns of polymorphism in Populus tremula.
    Ingvarsson PK
    Mol Biol Evol; 2010 Mar; 27(3):650-60. PubMed ID: 19837657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying gene selection in cancer through protein functional alteration bias.
    Brandes N; Linial N; Linial M
    Nucleic Acids Res; 2019 Jul; 47(13):6642-6655. PubMed ID: 31334812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.